Notiication of Major Share Holding

Cambridge, UK - 30th March 2020

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces: TR-1: Standard form for notification of major holdings

Download News

Back to all News